Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SPRC
SPRC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SPRC News
Biotech Stocks Pre-Market Trading Update
Jun 04 2026
NASDAQ.COM
NeuroThera Acquires 54% Stake in CliniQuantum
Jun 04 2026
Newsfilter
SciSparc Receives Approval to Acquire Stake in Israeli Tech Firm
May 29 2026
NASDAQ.COM
SciSparc Subsidiary Receives Approval for CliniQuantum Acquisition
May 28 2026
seekingalpha
SciSparc Acquires Controlling Interest in CliniQuantum
Mar 10 2026
Newsfilter
Clearmind Unveils Patent for Innovative Weight Loss Therapy
Mar 10 2026
Yahoo Finance
Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes
Jan 16 2026
NASDAQ.COM
SciSparc Ltd. Acquires Endoscopy Patents, Shares Drop 12.07%
Jan 13 2026
Benzinga
SciSparc (SPRC) Faces Nasdaq Compliance Risk Due to Negative Equity
Jan 13 2026
seekingalpha
SciSparc Secures Israeli Patent Enhancing Opioid Efficacy
Dec 30 2025
Globenewswire
SciSparc Secures Israeli Patent Enhancing Opioid Efficacy
Dec 30 2025
Newsfilter
Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 05 2025
Benzinga
SciSparc Acquires 55% Stake in NeuroThera for 40% Equity
Dec 02 2025
Newsfilter
Reasons Behind Today's Increase in SciSparc Stock
Nov 26 2025
Benzinga
SciSparc Acquires MUSE™ Endoscopic Patent Portfolio to Expand Global Market Reach
Nov 26 2025
Newsfilter
Clearmind Medicine Submits Israeli Patent for Innovative Non-Hallucinogenic Neuroplastogen Therapy for Depression
Nov 16 2025
Globenewswire
Show More News
